wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26825053-B742309F-D637-4124-A852-48E16A44CEEB
Q26825053-B742309F-D637-4124-A852-48E16A44CEEB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26825053-B742309F-D637-4124-A852-48E16A44CEEB
Metastatic castration-resistant prostate cancer: new therapies, novel combination strategies and implications for immunotherapy
P2860
Q26825053-B742309F-D637-4124-A852-48E16A44CEEB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26825053-B742309F-D637-4124-A852-48E16A44CEEB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d16f1337f5a712f855b16d97eb746dce3d100ad7
P2860
Phase III trials with docetaxel-based combinations for metastatic castration-resistant prostate cancer: time to learn from past experiences.